| Dr Christopher K Hwe, MD | |
|
1010 W La Veta Ave Ste 750, Orange, CA 92868-4312 | |
| (714) 361-6600 | |
| Not Available |
| Full Name | Dr Christopher K Hwe |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | 1010 W La Veta Ave Ste 750, Orange, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790149136 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | A151296 (California) | Primary |
| Entity Name | Southern California Permanente Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770515280 PECOS PAC ID: 6002729175 Enrollment ID: O20031110000678 |
News Archive
News outlets parse the particulars of how the fiscal deal will impact the health care system, and how the health industry is bracing for the next rounds in the budget battles.
Two University of Iowa researchers were part of a large multi-center study that provides compelling direct evidence of an association between prolonged residential radon exposure and lung cancer risk.
Bayer HealthCare Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved a new oral contraceptive (OC), SAFYRAL™ (drospirenone 3 mg/ ethinyl estradiol 30 mcg/ levomefolate calcium 451 mcg tablets and levomefolate calcium 451 mcg tablets). In women who choose an OC for birth control, SAFYRAL raises folate levels for the purpose of reducing the risk of rare neural tube defects (NTDs) in a pregnancy conceived while taking SAFYRAL or shortly after discontinuing it.
An ophthalmologist at Washington University School of Medicine in St. Louis is implanting radioactive discs in the eyes of children with a rare cancer in an attempt to save their vision and their eyes.
AMAG Pharmaceuticals, Inc. today announced that the European Commission has granted marketing authorization for ferumoxytol, an intravenous (IV) iron therapy to treat iron deficiency anemia (IDA) in adult patients with chronic kidney disease (CKD).
› Verified 6 days ago
| Entity Name | Comprehensive Pulmonary And Primary Care Of Orange County |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326552969 PECOS PAC ID: 3577822238 Enrollment ID: O20180125002574 |
News Archive
News outlets parse the particulars of how the fiscal deal will impact the health care system, and how the health industry is bracing for the next rounds in the budget battles.
Two University of Iowa researchers were part of a large multi-center study that provides compelling direct evidence of an association between prolonged residential radon exposure and lung cancer risk.
Bayer HealthCare Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved a new oral contraceptive (OC), SAFYRAL™ (drospirenone 3 mg/ ethinyl estradiol 30 mcg/ levomefolate calcium 451 mcg tablets and levomefolate calcium 451 mcg tablets). In women who choose an OC for birth control, SAFYRAL raises folate levels for the purpose of reducing the risk of rare neural tube defects (NTDs) in a pregnancy conceived while taking SAFYRAL or shortly after discontinuing it.
An ophthalmologist at Washington University School of Medicine in St. Louis is implanting radioactive discs in the eyes of children with a rare cancer in an attempt to save their vision and their eyes.
AMAG Pharmaceuticals, Inc. today announced that the European Commission has granted marketing authorization for ferumoxytol, an intravenous (IV) iron therapy to treat iron deficiency anemia (IDA) in adult patients with chronic kidney disease (CKD).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christopher K Hwe, MD 1010 W La Veta Ave Ste 750, Orange, CA 92868-4312 Ph: (714) 361-6600 | Dr Christopher K Hwe, MD 1010 W La Veta Ave Ste 750, Orange, CA 92868-4312 Ph: (714) 361-6600 |
News Archive
News outlets parse the particulars of how the fiscal deal will impact the health care system, and how the health industry is bracing for the next rounds in the budget battles.
Two University of Iowa researchers were part of a large multi-center study that provides compelling direct evidence of an association between prolonged residential radon exposure and lung cancer risk.
Bayer HealthCare Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved a new oral contraceptive (OC), SAFYRAL™ (drospirenone 3 mg/ ethinyl estradiol 30 mcg/ levomefolate calcium 451 mcg tablets and levomefolate calcium 451 mcg tablets). In women who choose an OC for birth control, SAFYRAL raises folate levels for the purpose of reducing the risk of rare neural tube defects (NTDs) in a pregnancy conceived while taking SAFYRAL or shortly after discontinuing it.
An ophthalmologist at Washington University School of Medicine in St. Louis is implanting radioactive discs in the eyes of children with a rare cancer in an attempt to save their vision and their eyes.
AMAG Pharmaceuticals, Inc. today announced that the European Commission has granted marketing authorization for ferumoxytol, an intravenous (IV) iron therapy to treat iron deficiency anemia (IDA) in adult patients with chronic kidney disease (CKD).
› Verified 6 days ago
Michael Cheng, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-456-7110 | |
Harry Nguyen, D.O. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-456-7002 | |
Millie Arora, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S, City Tower, Suite 400, Orange, CA 92868 Phone: 714-456-5691 Fax: 714-456-8874 | |
Dr. Sarah Jeanette Ettinger, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-456-5135 | |
Dr. Antonio Halais Frangieh, MD, MPH Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-456-7890 | |
Dr. Andy Yen-tang Lee, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-456-7890 | |
Dr. Jesse John Goitia Jr., M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-880-7812 |